表紙
市場調査レポート

DaVinci Biosciences, LLC:製品パイプライン分析

DaVinci Biosciences, LLC - Product Pipeline Review - 2015

発行 Global Markets Direct 商品コード 321942
出版日 ページ情報 英文 18 Pages
即納可能
価格
本日の銀行送金レート: 1USD=101.50円で換算しております。
Back to Top
DaVinci Biosciences, LLC:製品パイプライン分析 DaVinci Biosciences, LLC - Product Pipeline Review - 2015
出版日: 2015年05月13日 ページ情報: 英文 18 Pages
概要

DaVinci Biosciences, LLC は変性疾患治療の生物製薬を開発しているバイオテクノロジー企業で、細胞をベースとした治療薬を開発し、脊髄損傷、心血管疾患、神経疾患、関節炎、スポーツによる怪我、自己免疫疾患などの患者に提供しています。

当レポートでは、DaVinci Biosciences, LLC における治療薬開発パイプラインの現況と各開発段階の比較分析、薬剤標的、作用機序、投与経路、分子タイプ別の治療薬の評価、最新の企業ニュースや発表、後期段階および中止されたプロジェクトに関する情報などを提供しています。

DaVinci Biosciences, LLCの基本情報

DaVinci Biosciences, LLCの概要

  • 主要情報
  • 企業情報

DaVinci Biosciences, LLC: R&D の概要

  • 主な治療範囲

DaVinci Biosciences, LLC:パイプラインのレビュー

  • 開発段階別のパイプライン製品
  • 単剤製品

DaVinci Biosciences, LLC:パイプライン製品の概況

  • 初期段階にあるパイプライン製品
    • 創薬中の製品/併用療法モダリティ

DaVinci Biosciences, LLC:薬剤プロファイル

  • Stem Cell Therapy for Autoimmune Diseases
  • Stem Cell Therapy for Cardiovascular Diseases
  • Stem Cell Therapy for Neurological Diseases

DaVinci Biosciences, LLC:パイプライン分析

  • 分子タイプ別

DaVinci Biosciences, LLC:休止中のプロジェクト

DaVinci Biosciences, LLC:本社と子会社の所在地

付録

図表

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: GMDHC07089CDB

Summary

Global Markets Direct's, 'DaVinci Biosciences, LLC - Product Pipeline Review - 2015', provides an overview of the DaVinci Biosciences, LLC's pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of DaVinci Biosciences, LLC's, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of DaVinci Biosciences, LLC including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of DaVinci Biosciences, LLC's human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the DaVinci Biosciences, LLC's pipeline products

Reasons to buy

  • Evaluate DaVinci Biosciences, LLC's strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of DaVinci Biosciences, LLC in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the DaVinci Biosciences, LLC's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of DaVinci Biosciences, LLC and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of DaVinci Biosciences, LLC
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of DaVinci Biosciences, LLC and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • DaVinci Biosciences, LLC Snapshot
    • DaVinci Biosciences, LLC Overview
    • Key Information
    • Key Facts
  • DaVinci Biosciences, LLC - Research and Development Overview
    • Key Therapeutic Areas
  • DaVinci Biosciences, LLC - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
  • DaVinci Biosciences, LLC - Pipeline Products Glance
    • DaVinci Biosciences, LLC - Early Stage Pipeline Products
      • Discovery Products/Combination Treatment Modalities
  • DaVinci Biosciences, LLC - Drug Profiles
    • Stem Cell Therapy for Arthritis and Sports Injuries
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Stem Cell Therapy for Autoimmune Diseases
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Stem Cell Therapy for Cardiovascular Diseases
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Stem Cell Therapy for Neurological Diseases
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • DaVinci Biosciences, LLC - Pipeline Analysis
  • DaVinci Biosciences, LLC - Pipeline Products by Molecule Type
  • DaVinci Biosciences, LLC - Dormant Projects
  • DaVinci Biosciences, LLC - Locations And Subsidiaries
    • Head Office
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • DaVinci Biosciences, LLC, Key Information
  • DaVinci Biosciences, LLC, Key Facts
  • DaVinci Biosciences, LLC - Pipeline by Indication, 2015
  • DaVinci Biosciences, LLC - Pipeline by Stage of Development, 2015
  • DaVinci Biosciences, LLC - Monotherapy Products in Pipeline, 2015
  • DaVinci Biosciences, LLC - Discovery, 2015
  • DaVinci Biosciences, LLC - Pipeline by Molecule Type, 2015
  • DaVinci Biosciences, LLC - Dormant Developmental Projects,2015

List of Figures

  • DaVinci Biosciences, LLC - Pipeline by Top 10 Indication, 2015
Back to Top